Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Azd8205 – Application in Therapy and Current Clinical Research
AZD8205 Phase I/IIa Trial Result | ESMO 2024 | DelveInsight Business ...
AZD8205 for Endometrial Cancer Clinical Trial 2024 | Power
Study of AZD8205 Alone or with Other Cancer Drugs for Patients with ...
Azd8205 – Aplicación en terapia e investigaciones clínicas actuales
AZD8205 for Endometrial Cancer Clinical Trial 2025 | Power
Novel ADC AZD8205 demonstrates manageable safety profile and ...
ESMO: Novel ADC AZD8205 demonstrates manageable safety profile and ...
8205A Datasheet: MOSFET, N-Ch, 20V, 4A. Full specification with pinout ...
Badanie nad AZD8205 w leczeniu zaawansowanych lub przerzutowych ...
ESMO 2024: Novel ADC AZD8205 demonstrates manageable safety profile and ...
A Phase I/IIa Study of AZD8205 given alone or in Combination with ...
What Is A Technical Specification Definition at Tayla Hunter blog
Emerging ADC Targets: B7-H3 and B7-H4
2024年ESMO：抗体偶联药AZD8205 的首次人体临床试验数据公布，多个肿瘤类型迎来新希望！-MedSci.cn
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 ...
阿斯利康AZD批准8205临床试验申请-试药员招聘与临床试验信息平台
puxitatug samrotecan (AZD8205) / AstraZeneca
阿斯利康 B7-H4 ADC 国内临床即将启动！中国研发提速中_药物_Enhertu_研究
AZD8205（B7-H4 ADC）联合AZD5305的临床前研究 - 平头哥
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody ...
有效载荷（payload）的多样性：ADC药物未来开发的关键一环 - 脉脉
AZD8205-hIgG1 - Kyinno Bio
Safety and preliminary efficacy of puxitatug samrotecan (AZD8205) in ...
Puxitatug samrotecan drug-linker (AZD8205 drug-linker) | Drug-Linker ...
B7-H4 ADC AZD8205，首次披露临床结果_Insight_患者_治疗
阿斯利康：自研 B7-H4 ADC 国内启动临床_Insight_药物_包括
子宫内膜癌新药临床试验：ADC药物Puxitatug Samrotecan（AZD8205）-印塔健康官网
Abstract 1765: Discovery and first disclosure of AZD8205, a B7-H4 ...
AZD-8205(AZD-8205) - 药物靶点：B7-H4 x Top I_在研适应症：子宫内膜癌，恶性实体肿瘤，转移性子宫内膜恶性肿瘤 ...
2024年ESMO：抗体偶联药AZD8205 的首次人体临床试验数据公布，多个肿瘤类型迎来新希望！医药新闻-ByDrug-一站式医药资源共享 ...
AZD-8205(AZD-8205) - 药物靶点：B7-H4 x Top I_在研适应症：恶性实体肿瘤，转移性子宫内膜恶性肿瘤，腺样囊性癌 ...
靶向B7-H4，新型ADC药物AZD8205 在HR+/HER2–晚期乳腺癌临床研究中显疗效 - MedFind
Abstract 2947: Preclinical evaluation of a novel B7-H4 targeted ...
中美合作！抗癌新藥AZD8205有效治療癌症得到證實！ - 每日頭條
【重磅】晚期子宮內膜癌治療新突破！AZD8205 ADC療法疾病控制率超80% - 藥時事 Drugnews (@drugnews) | Dcard
ADC赛道全速狂飙的AZ丨汇总DS-8201临床研究及下一代布局 - 知乎
重压双抗ADC后，阿斯利康收购亘喜生物，布局双靶点CAR-T - 知乎
B7家族的泛癌种新星：B7-H4 - 知乎
2024年ESMO：抗体偶联药AZD8205 的首次人体临床试验数据公布，多个肿瘤类型迎来新希望！_腾讯新闻
阿斯利康自研ADC崛起? - 知乎
阿斯利康自研ADC崛起_患者_Elahere_药物
2024年ESMO：抗体偶联药AZD8205 的首次人体临床试验数据公布，多个肿瘤类型迎来新希望！ - 知乎
AOZ8205DI Datasheet(PDF) - Alpha & Omega Semiconductors
PK/PD/efficacy relationship of AZD5305 in a BRCA1m TNBC xenograft tumor ...
mTOR抑制剂(AZD8055)
AD8205 datasheet - The AD8205 is a single-supply difference amplifier
B7家族的多面光辉 - 知乎
saruparib (AZD5305) / AstraZeneca
AD8205 Single-Supply 42 V System Difference Amplifier Data Sheet
Free BRD Sample Template to Edit Online
AD8205WHRZ-RL ADI Universal Op Amp - Veswin Electronics
AZ820-2C-5DE datasheet - Subminiature DIP Relay
席卷全球，ADC研发进展 - 药时代DrugTimes
Puxitatug samrotecan (AZD 8205) | ADCs | MedChemExpress
阿斯利康自研ADC崛起_腾讯新闻
HD8205A Data Sheet | PDF | Field Effect Transistor | Diode
ESMO Breast 2025 Insights: Puxitatug Samrotecan (P-Sam, AZD8205) in HR+ ...
Immunological mechanisms and antibody-drug conjugates targeting B7-H3 ...
606O Initial results from a first-in-human study of the B7-H4-directed ...
广州东为智能科技有限公司 | H22
